In these pathways, the immune cells, upon stimulation by cytokines, ultimately differentiate into effector cells and kill tumor cells, such as the hematopoietic cell lineage, chemokine signaling pathway, IL-17 signaling pathways, and IL-12 and STAT4-dependent signaling pathway in Th1 cell development. This evidence concerns the gene IL17A and neoplasm.